Clinical Trial Update: A Study of ABT-751 in Patients With Colorectal Cancer [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial of ABT-751 in patients with colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ABT-751 (ABT-751)

Snippet

Sponsor: Abbott | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED